These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16989274)

  • 41. Transcutaneous vaccines--current and emerging strategies.
    Hirobe S; Okada N; Nakagawa S
    Expert Opin Drug Deliv; 2013 Apr; 10(4):485-98. PubMed ID: 23316778
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biocompatible Mater Constructed Microneedle Arrays as a Novel Vaccine Adjuvant- Delivery System for Cutaneous and Mucosal Vaccination.
    Wang T; Wang N
    Curr Pharm Des; 2015; 21(36):5245-55. PubMed ID: 26412356
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.
    Vajdy M; Srivastava I; Polo J; Donnelly J; O'Hagan D; Singh M
    Immunol Cell Biol; 2004 Dec; 82(6):617-27. PubMed ID: 15550120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Animal models for cutaneous vaccine delivery.
    Hirschberg HJ; van Riet E; Oosterhoff D; Bouwstra JA; Kersten GF
    Eur J Pharm Sci; 2015 Apr; 71():112-22. PubMed ID: 25686596
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of PLGA nanoparticle loaded dissolving microneedles and comparison with hollow microneedles in intradermal vaccine delivery.
    Mönkäre J; Pontier M; van Kampen EEM; Du G; Leone M; Romeijn S; Nejadnik MR; O'Mahony C; Slütter B; Jiskoot W; Bouwstra JA
    Eur J Pharm Biopharm; 2018 Aug; 129():111-121. PubMed ID: 29803720
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New Cutaneous Vaccine Adjuvant that STINGs a Little Less.
    Caucheteux SM; Piguet V
    J Invest Dermatol; 2016 Nov; 136(11):2127-2128. PubMed ID: 27772546
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The success of microneedle-mediated vaccine delivery into skin.
    Marshall S; Sahm LJ; Moore AC
    Hum Vaccin Immunother; 2016 Nov; 12(11):2975-2983. PubMed ID: 27050528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
    Bielinska AU; Janczak KW; Landers JJ; Makidon P; Sower LE; Peterson JW; Baker JR
    Infect Immun; 2007 Aug; 75(8):4020-9. PubMed ID: 17502384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transcutaneous immunization with influenza vaccines.
    Skountzou I; Kang SM
    Curr Top Microbiol Immunol; 2009; 333():347-68. PubMed ID: 19768414
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination.
    Zaharoff DA; Rogers CJ; Hance KW; Schlom J; Greiner JW
    Vaccine; 2007 Mar; 25(11):2085-94. PubMed ID: 17258843
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine.
    Durando P; Iudici R; Alicino C; Alberti M; de Florentis D; Ansaldi F; Icardi G
    Hum Vaccin; 2011; 7 Suppl():29-40. PubMed ID: 21245655
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Initiation of adaptive immune responses by transcutaneous immunization.
    Warger T; Schild H; Rechtsteiner G
    Immunol Lett; 2007 Mar; 109(1):13-20. PubMed ID: 17320194
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcutaneous antigen delivery system.
    Lee MY; Shin MC; Yang VC
    BMB Rep; 2013 Jan; 46(1):17-24. PubMed ID: 23351379
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An update on the use of laser technology in skin vaccination.
    Chen X; Wang J; Shah D; Wu MX
    Expert Rev Vaccines; 2013 Nov; 12(11):1313-23. PubMed ID: 24127871
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adjuvantation of epidermal powder immunization.
    Chen D; Erickson CA; Endres RL; Periwal SB; Chu Q; Shu C; Maa YF; Payne LG
    Vaccine; 2001 Apr; 19(20-22):2908-17. PubMed ID: 11282202
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine.
    Mikszta JA; Dekker JP; Harvey NG; Dean CH; Brittingham JM; Huang J; Sullivan VJ; Dyas B; Roy CJ; Ulrich RG
    Infect Immun; 2006 Dec; 74(12):6806-10. PubMed ID: 17030580
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.
    Srivastava A; Gowda DV; Madhunapantula SV; Shinde CG; Iyer M
    APMIS; 2015 Apr; 123(4):275-88. PubMed ID: 25630573
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
    Van Damme P; Oosterhuis-Kafeja F; Van der Wielen M; Almagor Y; Sharon O; Levin Y
    Vaccine; 2009 Jan; 27(3):454-9. PubMed ID: 19022318
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [From basic principles to clinical applications on transcutaneous vaccine].
    Okada N
    Yakugaku Zasshi; 2013; 133(12):1363-72. PubMed ID: 24292185
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dissolving Microneedle Arrays for Transdermal Delivery of Amphiphilic Vaccines.
    An M; Liu H
    Small; 2017 Jul; 13(26):. PubMed ID: 28544329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.